Dr Barbara Pistilli
- Spécialité
- Oncologue médical, expert sein
- Titre
- Chef du comité de pathologie mammaire
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study. (1 déc. 2024)
- Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer - A Clinical Review. (1 déc. 2024)
- Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01. (12 sept. 2024)
- Long-term behavioral symptom clusters among survivors of early-stage breast cancer. development and validation of a predictive model. (9 sept. 2024)
- Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis. (1 août 2024)